Walmart note sales to net $2.99B and C$4.98B

Q: How will Walmart's (WMT) new notes be held?

The notes will initially be issued and delivered only in book-entry form, represented by one or more global notes. Each U.S. global note will be payable to Cede & Co., as nominee of The Depository Trust Company; each Canadian global note will be payable to CDS & Co., as nominee of CDS Clearing and Depository Services Inc.

The notes will be issued initially only in book-entry form, represented by one or more global notes.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Walmart Inc. agreed, subject to the satisfaction of the conditions set forth therein, to sell to U.S. underwriters $750,000,000 of 5.050% Notes due 2029, $500,000,000 of 5.150% Notes due 2031, $1,000,000,000 of 5.350% Notes due 2033, and $750,000,000 of 5.550% Notes due 2036. It also agreed to sell to Canadian underwriters C$750,000,000 of 4.150% Notes due 2030, C$2,000,000,000 of 4.450% Notes due 2033, C$1,750,000,000 of 4.950% Notes due 2038, and C$500,000,000 of 5.250% Notes due 2056. The sales are expected to close October 23, 2026.

Net proceeds after underwriting discounts and before transaction expenses will be $2,985,035,000 for the U.S. Notes and C$4,978,607,500 for the Canadian Notes. The notes will be senior, unsecured debt securities ranking equally with Walmart’s other senior, unsecured debt obligations.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

U.S. Notes aggregate net proceeds: $2,985,035,000 Canadian Notes aggregate net proceeds: C$4,978,607,500 U.S. Notes aggregate public price: $2,996,035,000 +1 more

4 metrics

U.S. Notes aggregate net proceeds $2,985,035,000 After underwriting discounts, before transaction expenses

Canadian Notes aggregate net proceeds C$4,978,607,500 After underwriting discounts, before transaction expenses

U.S. Notes aggregate public price $2,996,035,000 Before underwriting discounts and transaction expenses

Canadian Notes aggregate public price C$4,997,757,500 Before underwriting discounts and transaction expenses

Key Terms

senior, unsecured debt securities, book-entry form, global notes, underwriting discount

4 terms

senior, unsecured debt securities financial

"The notes of each New Series will be senior, unsecured debt securities"

book-entry form financial

"initially issued and delivered in book-entry form only"

A book-entry form is an electronic record showing ownership of securities instead of a paper certificate; think of it like a bank account ledger that notes who owns shares. It matters to investors because it makes buying, selling and transferring securities faster, safer and cheaper by reducing paperwork, loss or forgery risk, and enabling easier settlement through brokers or a central depository.

global notes financial

"represented by one or more global notes"

underwriting discount financial

"after the underwriting discount, but before transaction expenses"

The underwriting discount is the fee that investment banks or broker-dealers keep when they buy securities from an issuer and resell them to the public; it’s the difference between the price paid to the company and the public offering price, shown per share or as a percentage. It matters to investors because it reduces the cash the company actually raises and is a cost built into the deal—like a sales commission—so a larger discount can mean higher issuance costs, tighter returns for new investors, and a signal about how much effort underwriters must expend to sell the offering.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much net proceeds will Walmart (WMT) receive from the note sales?

Net proceeds after underwriting discounts and before transaction expenses will be $2,985,035,000 for the U.S. Notes and C$4,978,607,500 for the Canadian Notes.

How will Walmart's (WMT) new notes be held?

The notes will initially be issued and delivered only in book-entry form, represented by one or more global notes. Each U.S. global note will be payable to Cede & Co., as nominee of The Depository Trust Company; each Canadian global note will be payable to CDS & Co., as nominee of CDS Clearing and Depository Services Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/23/2026 - 09:04 AM EDT Accepted by SEC EDGAR 10/23/2026 - 09:04 AM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 or 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported)

October 23, 2026 (October 19, 2026)

Walmart Inc.

(Exact name of registrant as specified in its charter)

001-06991

71-0415188

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

1 Customer Drive

Bentonville, AR 72716

(Address of Principal Executive Offices) (Zip code)

Registrant’s telephone number, including area code: (479) 273-4000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.10 per share	WMT	The Nasdaq Stock Market LLC
1.500% Notes due 2028	WMT28C	The Nasdaq Stock Market LLC
4.875% Notes due 2029	WMT29B	The Nasdaq Stock Market LLC
5.750% Notes due 2030	WMT30B	The Nasdaq Stock Market LLC
1.800% Notes due 2031	WMT31A	The Nasdaq Stock Market LLC
5.625% Notes due 2034	WMT34	The Nasdaq Stock Market LLC
5.250% Notes due 2035	WMT35A	The Nasdaq Stock Market LLC
4.875% Notes due 2039	WMT39	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01.

Other Events.

Walmart Inc., a Delaware corporation (the “Company”), and BNP Paribas Securities Corp., BofA Securities, Inc., Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Wells Fargo Securities, LLC, acting for themselves and as representatives of the other several underwriters named in Schedule I to the U.S. Offering Pricing Agreement (as defined below) (collectively, the “U.S. Offering Underwriters”), have entered into a Pricing Agreement, dated October 19, 2026 (the “U.S. Offering Pricing Agreement”), pursuant to which, subject to the satisfaction of the conditions set forth therein, the Company has agreed to sell to the U.S. Offering Underwriters, and the U.S. Offering Underwriters have agreed to purchase from the Company, $750,000,000 aggregate principal amount of the Company’s 5.050% Notes Due 2029 (the “2029 Notes”), $500,000,000 aggregate principal amount of the Company’s 5.150% Notes Due 2031 (the “2031 Notes”), $1,000,000,000 aggregate principal amount of the Company’s 5.350% Notes Due 2033 (the “2033 U.S. Notes”) and $750,000,000 aggregate principal amount of the Company’s 5.550% Notes Due 2036 (the “2036 Notes” and, collectively with the 2029 Notes, the 2031 Notes and the 2033 U.S. Notes, the “U.S. Notes”). The U.S. Offering Pricing Agreement incorporates by reference the terms and conditions of an Underwriting Agreement, dated October 19, 2026, between the Company and the U.S. Offering Underwriters (the “U.S. Offering Underwriting Agreement” and, together with the U.S. Offering Pricing Agreement, the “U.S. Offering Agreement”). The Company and the U.S. Offering Underwriters expect to consummate the sale and purchase of the U.S. Notes pursuant to the U.S. Offering Agreement on October 23, 2026.

The Company and Merrill Lynch Canada Inc., Scotia Capital Inc. and TD Securities Inc., acting for themselves and as representatives of the other several underwriters named in Schedule I to the Canadian Offering Pricing Agreement (as defined below) (collectively, the “Canadian Offering Underwriters”), have entered into a Pricing Agreement, dated October 19, 2026 (the “Canadian Offering Pricing Agreement”), pursuant to which, subject to the satisfaction of the conditions set forth therein, the Company has agreed to sell to the Canadian Offering Underwriters, and the Canadian Offering Underwriters have agreed to purchase from the Company, C$750,000,000 aggregate principal amount of the Company’s 4.150% Notes Due 2030 (the “2030 Notes”), C$2,000,000,000 aggregate principal amount of the Company’s 4.450% Notes Due 2033 (the “2033 Canadian Notes”), C$1,750,000,000 aggregate principal amount of the Company’s 4.950% Notes Due 2038 (the “2038 Notes”) and C$500,000,000 aggregate principal amount of the Company’s 5.250% Notes Due 2056 (the “2056 Notes” and, collectively with the 2030 Notes, the 2033 Canadian Notes and the 2038 Notes, the “Canadian Notes” and, collectively with the U.S. Notes, the “Notes”). The Canadian Offering Pricing Agreement incorporates by reference the terms and conditions of an Underwriting Agreement, dated October 19, 2026, between the Company and the Canadian Offering Underwriters (the “Canadian Offering Underwriting Agreement” and, together with the Canadian Offering Pricing Agreement, the “Canadian Offering Agreement”). The Company and the Canadian Offering Underwriters expect to consummate the sale and purchase of the Canadian Notes pursuant to the Canadian Offering Agreement on October 23, 2026.

The 2029 Notes will be sold to the public at a price equal to 99.994% of the aggregate principal amount of the 2029 Notes. The net proceeds to the Company from the sale of the 2029 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2029 Notes, will be $748,080,000.

The 2030 Notes will be sold to the public at a price equal to 99.996% of the aggregate principal amount of the 2030 Notes. The net proceeds to the Company from the sale of the 2030 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2030 Notes, will be C$747,720,000.

The 2031 Notes will be sold to the public at a price equal to 99.800% of the aggregate principal amount of the 2031 Notes. The net proceeds to the Company from the sale of the 2031 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2031 Notes, will be $497,250,000.

The 2033 U.S. Notes will be sold to the public at a price equal to 99.873% of the aggregate principal amount of the 2033 U.S. Notes. The net proceeds to the Company from the sale of the 2033 U.S. Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2033 U.S. Notes, will be $994,730,000.

The 2033 Canadian Notes will be sold to the public at a price equal to 99.946% of the aggregate principal amount of the 2033 Canadian Notes. The net proceeds to the Company from the sale of the 2033 Canadian Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2033 Canadian Notes, will be C$1,991,520,000.

The 2036 Notes will be sold to the public at a price equal to 99.780% of the aggregate principal amount of the 2036 Notes. The net proceeds to the Company from the sale of the 2036 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2036 Notes, will be $744,975,000.

The 2038 Notes will be sold to the public at a price equal to 99.991% of the aggregate principal amount of the 2038 Notes. The net proceeds to the Company from the sale of the 2038 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2038 Notes, will be C$1,742,842,500.

The 2056 Notes will be sold to the public at a price equal to 99.805% of the aggregate principal amount of the 2056 Notes. The net proceeds to the Company from the sale of the 2056 Notes, after the underwriting discount, but before transaction expenses allocable to the sale of the 2056 Notes, will be C$496,525,000.

The U.S. Notes and Canadian Notes will be sold to the public at an aggregate price of $2,996,035,000 and C$4,997,757,500, respectively, before underwriting discounts and transaction expenses allocable to the sale of the U.S. Notes and Canadian Notes, as applicable. The aggregate net proceeds to the Company from the sale of the U.S. Notes and Canadian Notes, after underwriting discounts, but before transaction expenses allocable to the sale of the Notes, will be $2,985,035,000 and C$4,978,607,500, respectively.

The 2029 Notes will constitute part of the Company’s newly created series of 5.050% Notes Due 2029 (the “2029 Series”), the 2030 Notes will constitute part of the Company’s newly created series of 4.150% Notes Due 2030 (the “2030 Series”), the 2031 Notes will constitute part of the Company’s newly created series of 5.150% Notes Due 2031 (the “2031 Series”), the 2033 U.S. Notes will constitute part of the Company’s newly created series of 5.350% Notes Due 2033 (the “2033 U.S. Series”), the 2033 Canadian Notes will constitute part of the Company’s newly created series of 4.450% Notes Due 2033 (the “2033 Canadian Series”), the 2036 Notes will constitute part of the Company’s newly created series of 5.550% Notes Due 2036 (the “2036 Series”), the 2038 Notes will constitute part of the Company’s newly created series of 4.950% Notes Due 2038 (the “2038 Series”) and the 2056 Notes will constitute part of the Company’s newly created series of 5.250% Notes Due 2056 (the “2056 Series” and, collectively with the 2029 Series, the 2030 Series, the 2031 Series, the 2033 U.S. Series, the 2033 Canadian Series, the 2036 Series and the 2038 Series, the “New Series”). The Notes of each New Series will be senior, unsecured debt securities of the Company and will rank equally with each other and with all of the other senior, unsecured debt obligations of the Company.

The New Series were created and established, and the terms and conditions of each New Series were established, by action of the Company and an authorized officer of the Company pursuant to, and in accordance with, the terms of the Indenture, dated as of July 19, 2005, as amended and supplemented (the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as successor trustee (the “Trustee”), and the Indenture and the related series terms certificates pursuant to the Indenture will govern the Notes of each New Series. The respective terms of the 2029 Notes, the 2031 Notes, the 2033 U.S. Notes and the 2036 Notes are as set forth in the Indenture and in the forms of the Global Notes (referred to below) that will represent the Notes of the 2029 Series, the 2031 Series, the 2033 U.S. Series and the 2036 Series, respectively, to be sold pursuant to the U.S. Offering Pricing Agreement. The respective terms of the 2030 Notes, the 2033 Canadian Notes, the 2038 Notes and the 2056 Notes are as set forth in the Indenture and in the forms of the Global Notes (referred to below) that will represent the Notes of the 2030 Series, the 2033 Canadian Series, the 2038 Series and the 2056 Series, respectively, to be sold pursuant to the Canadian Offering Pricing Agreement.

The material terms of the U.S. Notes are described in the Company’s prospectus supplement dated October 19, 2026, which relates to the offer and sale of the U.S. Notes (the “U.S. Prospectus Supplement”), and the Company’s prospectus dated December 4, 2023, which relates to the offer and sale from time to time of an

indeterminate amount of the Company’s debt securities, including the Notes (the “Prospectus”). The U.S. Prospectus Supplement, together with the Prospectus, was filed by the Company with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended (the “Securities Act”), on October 21, 2026, in connection with the offer and sale of the U.S. Notes. A Final Term Sheet, dated October 19, 2026, relating to, and setting forth certain terms of, the U.S. Notes was filed with the Commission pursuant to Rule 433 under the Securities Act on October 20, 2026.

The material terms of the Canadian Notes are described in the Company’s prospectus supplement dated October 19, 2026, which relates to the offer and sale of the Canadian Notes (the “Canadian Prospectus Supplement”), and the Prospectus. The Canadian Prospectus Supplement, together with the Prospectus, was filed by the Company with the Commission pursuant to Rule 424(b)(5) under the Securities Act on October 21, 2026, in connection with the offer and sale of the Canadian Notes. A Final Term Sheet, dated October 19, 2026, relating to, and setting forth certain terms of, the Canadian Notes was filed with the Commission pursuant to Rule 433 under the Securities Act on October 20, 2026.

The Notes of each New Series will be initially issued and delivered in book-entry form only and will be represented by one or more global notes, which will be in definitive, fully registered form without interest coupons. The 2029 Notes will be represented by two global notes, one of which will be in the principal amount of $500,000,000 and one of which will be in the principal amount of $250,000,000 (the “2029 Global Notes”). The 2031 Notes will be represented by one global note in the principal amount of $500,000,000 (the “2031 Global Note”). The 2033 U.S. Notes will be represented by two global notes, each of which will be in the principal amount of $500,000,000 (the “2033 U.S. Global Notes”). The 2036 Notes will be represented by two global notes, one of which will be in the principal amount of $500,000,000 and one of which will be in the principal amount of $250,000,000 (the “2036 Global Notes” and, collectively with the 2029 Global Notes, the 2031 Global Note and the 2033 U.S. Global Notes, the “U.S. Global Notes”). Each U.S. Global Note will be payable to Cede & Co., a New York corporation, as nominee of The Depository Trust Company. The U.S. Global Notes will be executed by the Company and authenticated by the Trustee in accordance with the Indenture.

The 2030 Notes will be represented by one global note, which will be in the principal amount of C$750,000,000 (the “2030 Global Note”). The 2033 Canadian Notes will be represented by one global note, which will be in the principal amount of C$2,000,000,000 (the “2033 Canadian Global Note”). The 2038 Notes will be represented by one global note, which will be in the principal amount of C$1,750,000,000 (the “2038 Global Note”). The 2056 Notes will be represented by one global note in the principal amount of C$500,000,000 (the “2056 Global Note” and, collectively with the 2030 Global Note, the 2033 Canadian Global Note and the 2038 Global Note, the “Canadian Global Notes” and, the Canadian Global Notes together with the U.S. Global Notes, the “Global Notes”). Each Canadian Global Note will be payable to CDS & Co., as nominee of CDS Clearing and Depository Services Inc. The Canadian Global Notes will be executed by the Company and authenticated by the Trustee through the Trustee’s authenticating agent in accordance with the Indenture.

Filed as exhibits to this Current Report on Form 8-K are: (i) the U.S. Offering Pricing Agreement; (ii) the Canadian Offering Pricing Agreement; (iii) the U.S. Offering Underwriting Agreement; (iv) the Canadian Offering Underwriting Agreement; (v) the Series Terms Certificate Pursuant to the Indenture Relating to 5.050% Notes Due 2029 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2029 Series in accordance with the Indenture; (vi) the Series Terms Certificate Pursuant to the Indenture Relating to 4.150% Notes Due 2030 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2030 Series in accordance with the Indenture; (vii) the Series Terms Certificate Pursuant to the Indenture Relating to 5.150% Notes Due 2031 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2031 Series in accordance with the Indenture; (viii) the Series Terms Certificate Pursuant to the Indenture Relating to 5.350% Notes Due 2033 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2033 U.S. Series in accordance with the Indenture; (ix) the Series Terms Certificate Pursuant to the Indenture Relating to 4.450% Notes Due 2033 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2033 Canadian Series in accordance with the Indenture; (x) the Series Terms Certificate Pursuant to the Indenture Relating to 5.550% Notes Due 2036 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2036 Series in accordance with the Indenture; (xi) the

Series Terms Certificate Pursuant to the Indenture Relating to 4.950% Notes Due 2038 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2038 Series in accordance with the Indenture; (xii) the Series Terms Certificate Pursuant to the Indenture Relating to 5.250% Notes Due 2056 of the Company, which was executed in accordance with the Indenture and evidences the establishment of the terms and conditions of the 2056 Series in accordance with the Indenture; (xiii) the form of 2029 Global Notes; (xiv) the form of 2030 Global Note; (xv) the form of 2031 Global Note; (xvi) the form of 2033 U.S. Global Notes; (xvii) the form of 2033 Canadian Global Note; (xviii) the form of 2036 Global Notes; (xix) the form of 2038 Global Note; (xx) the form of 2056 Global Note; and (xxi) the opinion of Hunton Andrews Kurth LLP, counsel to the Company, regarding the legality of the issuance and sale of the Notes. The descriptions of such exhibits in this Current Report on Form 8-K are qualified in their entirety by reference to the full copies of such exhibits filed hereto, which are incorporated herein by reference.

The Company is offering and selling the Notes under the Company’s Registration Statement on Form S-3ASR (File No. 333-275878) (the “Registration Statement”), which registration statement relates to the offer and sale on a delayed basis from time to time of an indeterminate amount of the Company’s debt securities. This Current Report on Form 8-K is being filed in connection with the offer and sale of the Notes as described herein and to file with the Commission, in connection with the Registration Statement, the documents and instruments attached hereto as exhibits.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

The following documents are filed as exhibits to this Current Report on Form 8-K:


1.1		Pricing Agreement, dated October 19, 2026, between the Company and the U.S. Offering Underwriters party thereto, together with the Underwriting Agreement, dated October 19, 2026, between the Company and the Underwriters party thereto

1.2		Pricing Agreement, dated October 19, 2026, between the Company and the Canadian Offering Underwriters party thereto, together with the Underwriting Agreement, dated October 19, 2026, between the Company and the Underwriters party thereto

4.1		Series Terms Certificate Pursuant to the Indenture Relating to 5.050% Notes Due 2029 of the Company

4.2		Series Terms Certificate Pursuant to the Indenture Relating to 4.150% Notes Due 2030 of the Company

4.3		Series Terms Certificate Pursuant to the Indenture Relating to 5.150% Notes Due 2031 of the Company

4.4		Series Terms Certificate Pursuant to the Indenture Relating to 5.350% Notes Due 2033 of the Company

4.5		Series Terms Certificate Pursuant to the Indenture Relating to 4.450% Notes Due 2033 of the Company

4.6		Series Terms Certificate Pursuant to the Indenture Relating to 5.550% Notes Due 2036 of the Company

4.7		Series Terms Certificate Pursuant to the Indenture Relating to 4.950% Notes Due 2038 of the Company

4.8		Series Terms Certificate Pursuant to the Indenture Relating to 5.250% Notes Due 2056 of the Company

4.9		Form of Global Notes to represent the 5.050% Notes Due 2029 of the Company

4.10		Form of Global Note to represent the 4.150% Notes Due 2030 of the Company

4.11		Form of Global Note to represent the 5.150% Notes Due 2031 of the Company

4.12		Form of Global Notes to represent the 5.350% Notes Due 2033 of the Company

4.13		Form of Global Note to represent the 4.450% Notes Due 2033 of the Company

4.14		Form of Global Notes to represent the 5.550% Notes Due 2036 of the Company

4.15		Form of Global Note to represent the 4.950% Notes Due 2038 of the Company

4.16		Form of Global Note to represent the 5.250% Notes Due 2056 of the Company

5.1		Legality Opinion of Hunton Andrews Kurth LLP, counsel to the Company, dated October 23, 2026

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: October 23, 2026


WALMART INC.

By:		/s/ Joseph M. Ruschell
Name:		Joseph M. Ruschell
Title:		Senior Vice President and Chief Counsel, Office of the Corporate Secretary

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

23 documents

Walmart note sales to net $2.99B and C$4.98B

Rhea-AI Filing Summary

8-K Event Classification

Key Figures

Key Terms

FAQ

How much net proceeds will Walmart (WMT) receive from the note sales?

How will Walmart's (WMT) new notes be held?

Filing Exhibits & Attachments

Other Documents

Keep reading

More on WMT

Trending in the feed

From our desk